Mornex R, Badet C, Peyrin L
Service d'Endocrinologie, Pavillon X, Hôpital Edouard Herriot, Lyon, France.
J Endocrinol Invest. 1992 Oct;15(9):643-9. doi: 10.1007/BF03345808.
We report 14 patients (9 males, 5 females) aged 15-59 years, treated for malignant pheochromocytoma. These patients were observed during the 1966-1990 period along with 68 other patients presenting benign pheochromocytomas. From the initial general presentation of the 14 patients, two groups could be individualized. In seven patients, the initial presentation seemed benign. After the excision, the recovery was complete, but patients recurred on average 7.8 yr later (range 1-22 yr). Tumors were intraadrenal in six cases (5 single, 1 bilateral) and extraadrenal in one case. In the seven remaining patients, malignancy was evident from the first examination. The tumors were intraadrenal in 2 cases, extraadrenal in 5 cases. Frequency of extraadrenal locations (6/14) was in this series significantly higher than in benign forms (9/68). Diagnosis of malignancy was based on metastases in 12 cases (lymph nodes in 5, bones in 5, liver in 4, lung in 2, brain in 1) and on peritumoral extension in 2 cases. No biological specificity was detected in urinary excretion of catecholamines or its metabolites. In 6 patients so far studied, an uptake of 131I MIBG was found in the tumor and/or metastases. Four patients received therapeutic doses of 131I MIBG and in three of them, this treatment led to a good result within a follow-up range of 12 to 66 months.(ABSTRACT TRUNCATED AT 250 WORDS)
我们报告了14例年龄在15至59岁之间接受恶性嗜铬细胞瘤治疗的患者(9例男性,5例女性)。在1966年至1990年期间对这些患者进行了观察,同时还有68例患有良性嗜铬细胞瘤的患者。从这14例患者最初的总体表现来看,可以分为两组。7例患者最初的表现看似良性。切除术后恢复完全,但患者平均在7.8年后复发(范围为1至22年)。肿瘤位于肾上腺内6例(5例单发,1例双侧),肾上腺外1例。其余7例患者从首次检查时恶性就很明显。肿瘤位于肾上腺内2例,肾上腺外5例。在本系列中,肾上腺外部位的发生率(6/14)显著高于良性病例(9/68)。恶性诊断基于12例转移(5例为淋巴结转移,5例为骨转移,4例为肝转移,2例为肺转移,1例为脑转移)和2例肿瘤周围浸润。在儿茶酚胺及其代谢产物的尿排泄中未检测到生物学特异性。在目前研究的6例患者中,在肿瘤和/或转移灶中发现了131I MIBG摄取。4例患者接受了治疗剂量的131I MIBG,其中3例在12至66个月的随访范围内治疗效果良好。(摘要截短至250字)